publication venue for
- Case report and mini-review: Sarcina ventriculi in the stomach of an 80-year-old female. 2023
- Detection of mecA-mediated methicillin resistance and evaluation of disk-diffusion antimicrobial susceptibility characteristics of Staphylococcus saprophyticus isolates from geographically diverse locations: Staphylococcus saprophyticus antibiotic susceptibility testing.. 110. 2024
- Rapid detection of SARS-CoV-2 variants of concern by single nucleotide polymorphism genotyping using TaqMan assays.. 104. 2022
- Predicting β-lactam resistance using whole genome sequencing in Klebsiella pneumoniae: the challenge of β-lactamase inhibitors.. 98. 2020
- Evaluation of a human adenovirus viral load assay using the Altona RealStar® PCR test.. 90. 2017
- False-positive rifampin resistant results with Xpert MTB/RIF version 4 assay in clinical samples with a low bacterial load.. 85. 2016
- A multiplex PCR/LDR assay for simultaneous detection and identification of the NIAID category B bacterial food and water-borne pathogens.. 79. 2014
- Multicenter validation of the VITEK MS v2.0 MALDI-TOF mass spectrometry system for the identification of fastidious gram-negative bacteria.. 78. 2013
- Identification of CTX-M β-lactamases among Escherichia coli from the community in New York City.. 72. 2012
- Identification of a novel Acinetobacter baumannii clone in a US hospital outbreak by multilocus polymerase chain reaction/electrospray-ionization mass spectrometry.. 72. 2011
- Prevalence, persistence, and microbiology of Staphylococcus aureus nasal carriage among hemodialysis outpatients at a major New York Hospital.. 70. 2011
- Identification of CTX-M beta-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilities.. 66. 2010
- Limiting false-positive polymerase chain reaction results: detection of DNA and mRNA to differentiate viable from dead bacteria.. 64. 2009
- Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem.. 64. 2009
- Validation of the MycoAlign system for Mycobacterium spp. identification.. 59. 2007
- In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998.. 37. 2000
- Practical approach to the identification of clinically relevant Enterococcus species.. 34. 1999
- Pseudomonas aeruginosa ribotyping: stability and interpretation of ribosomal operon restriction patterns.. 25. 1996
- Comparative usefulness of ribotyping, exotoxin A genotyping, and SalI restriction fragment length polymorphism analysis for Pseudomonas aeruginosa lineage assessment.. 24. 1996
- Evaluation of new technology in the clinical microbiology laboratory.. 23. 1995
- Multicenter in vitro comparative study of fluoroquinolones after four years of widespread clinical use.. 18. 1994
- Activity of cefotaxime/desacetylcefotaxime with two aminoglycosides against gram-negative pathogens: an example of interactive synergy.. 12. 1989
- Cefazolin as a class representative for oral cephalosporins and uncomplicated urinary tract infections caused by indicated Enterobacteriaceae.. 77. 2013
- Blastomycosis during pregnancy: a case report and review of the literature. 2017